 |
 |
 |
 |
 |
|||||||
 |
|
 |
INTELLECTUAL PROPERTYLacPro currently holds two issued U.S. patents. These patents have broad claims covering the composition and use of Lactobacillus delbrueckii spp. bulgaricus B-30892 in gastrointestinal health and obesity. Patent No. Title and Award Date6,696,057 Composition and method for treatment of gastrointestinal disorders and hyperlipidemia. February 24, 2004
6,641,808 Composition for treatment of obesity. November 4, 2003. Pending Novel Lactobacillus bulgaricus Strain and Compositions, filed June 2006. Pending Methods of Use of Novel Lactobacillus bulgaricus Strain, filed June 2006. LacPro has filed additional patent applications covering the Lactobacillus delbrueckii spp. bulgaricus B-30892 strain and broadly covering compositions, as well as applications for usage. These patent applications, along with issued patents, serve to strengthen LacPro’s already strong proprietary position regarding its Lactobacillus delbrueckii spp. bulgaricus B-30892 strain. Ice Miller LLP, Indianapolis, IN, has handled all patent documentation and filings for the company. |
 |
|||||||||
 |
 |
 |
|||||||
 |
LacPro Industries, LLC 2020 E. Washington Blvd. Suite 700 Fort Wayne, IN 46803 |
 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
 |
 |
 |
||